Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway
Robin C. Muise‐Helmericks(Medical University of South Carolina), Neal Rosen(Memorial Sloan Kettering Cancer Center), Alfonso Bellacosa(Fox Chase Cancer Center), H. Leighton Grimes(Cincinnati Children's Hospital Medical Center), Scott Malstrom(Fox Chase Cancer Center), Philip N. Tsichlis(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 512
Related Papers
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
|Cancer Research|2006|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
|Nature|2011|1.4k
BRAF mutation predicts sensitivity to MEK inhibition
|Nature|2005|1.3k